Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy
about
Select host restriction factors are associated with HIV persistence during antiretroviral therapy.Human Galectin-9 Is a Potent Mediator of HIV Transcription and ReactivationCCR5-Δ32 Heterozygosity, HIV-1 Reservoir Size, and Lymphocyte Activation in Individuals Receiving Long-term Suppressive Antiretroviral Therapy.Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection.
P2860
Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Decreased HIV type 1 transcrip ...... ressive antiretroviral therapy
@ast
Decreased HIV type 1 transcrip ...... ressive antiretroviral therapy
@en
Decreased HIV type 1 transcrip ...... ressive antiretroviral therapy
@nl
type
label
Decreased HIV type 1 transcrip ...... ressive antiretroviral therapy
@ast
Decreased HIV type 1 transcrip ...... ressive antiretroviral therapy
@en
Decreased HIV type 1 transcrip ...... ressive antiretroviral therapy
@nl
prefLabel
Decreased HIV type 1 transcrip ...... ressive antiretroviral therapy
@ast
Decreased HIV type 1 transcrip ...... ressive antiretroviral therapy
@en
Decreased HIV type 1 transcrip ...... ressive antiretroviral therapy
@nl
P2093
P2860
P50
P356
P1476
Decreased HIV type 1 transcrip ...... ressive antiretroviral therapy
@en
P2093
Charlene Wang
Christopher D Pilcher
Douglas D Richman
Elizabeth Sinclair
Leslie R Cockerham
Matthew C Strain
Mohamed Abdel-Mohsen
Steven M Lada
Steven Yukl
Teri Liegler
P2860
P304
P356
10.1093/INFDIS/JIU338
P407
P577
2014-06-16T00:00:00Z